Oxidative Degradation of 6-Selenoguanosine in Aqueous Solutions
作者:A.J. Repta、Y.A. Beltagy
DOI:10.1002/jps.2600700615
日期:1981.6
The degradation of 6-selenoguanosine (NSC 137679) (I) in water and in various buffer systems was investigated. Drug degradation in aqueous media was monitored by high-pressure of I in various chromatography. Some kinetic aspects of the degradation of I in various buffer systems at 25 degrees also were studied spectrophotometrically. The degradation, which requires oxygen, involves autoxidation of I
The toxic effects of platinum compounds used in chemotherapy can be negated by the use of a selenium-containing compound. A new selenium-containing platinum compound has been found to be useful as a so-called platinum compound type anti-cancer medicine which can self-detoxify platinum toxicity.
Antioxidants in purification, stabilization, and formulation of the antineoplastic agent 6-selenoguanosine
作者:Y.A. Beltagy、W. Waugh、A.J. Repta
DOI:10.1002/jps.2600691012
日期:1980.10
6-Selenoguanosine (NSC 137679) was stablized and formulated as a lyophilized parenteral paroduct using ascorbic acid as an antioxidant. In addition to preventing the oxidation of 6-selenoguanosine to the corresponding diselenide in aqueous solution, ascorbic acid reduced the diselenide already in the bulk drug. Dithioerythritol and sodium bisulfite also were evaluated as antioxidants. Dithioerythritol